Stem cell therapy: A novel & futuristic treatment modality for disaster injuries

Indian Journal of Medical Research

Volumn 135, Issue 1, 2012, Pages 15-25

  Gurudutta, G U ^a   Satija, Neeraj Kumar ^a   Singh, Vimal Kishor ^a   Verma, Yogesh Kumar ^a   Gupta, Pallavi ^a   Tripathi, R P ^a  

^a INSTITUTE OF NUCLEAR MEDICINE AND ALLIED SCIENCES   (India)

Author keywords

Critical injuries; Disasters; Haematopoietic stem cells; Mesenchymal stem cells; Stem cell therapy

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; INTERLEUKIN 10; KRUPPEL LIKE FACTOR 4; NERVE CELL ADHESION MOLECULE; OCTAMER TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR RUNX2; TRANSCRIPTION FACTOR SOX2; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN;

ACCIDENTAL INJURY; ACUTE KIDNEY FAILURE; ACUTE RADIATION SYNDROME; ALLOPATHY; ARTICLE; ATOMIC BOMB SURVIVOR; AUTOLOGOUS BONE MARROW TRANSPLANTATION; AUTOLOGOUS STEM CELL TRANSPLANTATION; BONE MARROW CELL; BONE REMODELING; BURN; CELL DIFFERENTIATION; CELL FUNCTION; CELL ISOLATION; CELL MIGRATION; CELL POPULATION; CELL PROLIFERATION; CLINICAL TRIAL (TOPIC); COLONY FORMING UNIT; DISEASE COURSE; DNA MODIFICATION; EARTHQUAKE; EMBRYONIC STEM CELL; FIBROBLAST; FIRE; GASTROINTESTINAL DISEASE; GRAFT VERSUS HOST REACTION; GUNSHOT INJURY; HEMATOPOIETIC STEM CELL; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; INFECTION SENSITIVITY; KIDNEY INJURY; LETHAL DOSE; LEUKEMIA; LIVER CELL; LIVER INJURY; MEDICAL ETHICS; MESENCHYMAL STEM CELL; MUSCULOSKELETAL INJURY; NONHUMAN; OSTEOBLAST; PLURIPOTENT STEM CELL; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; QUALITY OF LIFE; RADIATION DOSE; RADIATION EXPOSURE; RADIOSENSITIVITY; SEPSIS; SIGNAL TRANSDUCTION; SKIN INJURY; SPINAL CORD INJURY; STEM CELL; STEM CELL TRANSPLANTATION; VOLCANO; WAR;

ACUTE RADIATION SYNDROME; DISASTERS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MASS CASUALTY INCIDENTS; MESENCHYMAL STEM CELL TRANSPLANTATION; MUSCULOSKELETAL SYSTEM; NUCLEAR REACTORS; SPINAL CORD INJURIES; TISSUE THERAPY; WOUNDS AND INJURIES;

EID: 84857805893     PISSN: 09715916     EISSN: None     Source Type: Journal    
DOI: 10.4103/0971-5916.93419     Document Type: Article

References (121)

1. Herodin F, Mayol J-F, Mourcin F, Drouet M. Which place for stem cell therapy in the treatment of acute radiation syndrome? Folia Histochemica Et Cytobiologica 2005; 43: 223-7.
2. Chin FKC. Scenario of a dirty bomb in an urban environment and acute management of radiation poisoning and injuries. Singapore Med J 2007; 48: 950-6.
3. Behbehani A, Hasaniya N, Abu-Zidan F, Merei J. War injuries during the Gulf War: experience of a teaching hospital in Kuwait. Ann R Coll Surg Engl 1994; 76: 407-11.
4. Peek-Asa C, Kraus JF, Bourque LB, Vimalachandra D, Yu J, Abrams J. Fatal and hospitalized injuries resulting from the 1994 Northridge earthquake. Int J Epidemiol 1998; 27: 459-65.
5. Salama OMM. Craniofacial war injuries. Eastern Mediterranean Health J 2006; 12: 919-22.
6. Siminovitch L, McCulloch EA, Till JE. The distribution of colony-forming cells among spleen colonies. J Cellular Comp Physiol 1963; 62: 327-36.
7. Friendenstein AJ, Gorskaja U, Kulagina NN. Fibroblast precursors in normal and irradiated mouse hematopoietic organs. Exp Hematol 1976; 4: 267-74.
8. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, et al. Embryonic stem cell lines derived from human blastocysts. Science 1998; 282: 1145-7.
9. Wilmut I, Beaujean N, de Sousa PA, Dinnyes A, King TJ, Paterson LA, et al. Somatic cell nuclear transfer. Nature 2002; 419: 583-6.
10. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006; 126: 663-76.
11. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007; 131: 861-72.
12. Blanpain C, Horsley V, Fuchs E. Epithelial stem cells: turning over new leaves. Cell 2007; 128: 445-58.
13. Stingl J, Eirew P, Ricketson I, Shackleton M, Vaillant F, Choi D, et al. Purification and unique properties of mammary epithelial stem cells. Nature 2006; 439: 993-7.
14. Szilvassy SJ. The biology of hematopoietic stem cells. Arch Med Res 2003; 34: 446-60.
15. Bordignon C. Stem-cell therapies for blood diseases. Nature 2006; 441: 1100-2.
16. Hess DC, Borlongan CV. Stem cells and neurological diseases. Cell Prolif 2008; 41 (Suppl 1): 94-114.
17. Segers VFM, Lee RT. Stem-cell therapy for cardiac disease. Nature 2008; 451: 937-42.
18. Bruder SP, Jaiswal N, Haynesworth SE. Growth kinetics, self-renewal and the osteogenic potential of purified human mesenchymal stem cells during extensive subcultivation and following cryopreservation. J Cell Biochem 1997; 64: 278-94.
19. Mohyeddin-Bonab M, Alimoghaddam K, Talebian F, Ghaffari SH, Ghavamzadeh A, Nikbin B. Aging of mesenchymal stem cells in vitro. BMC Cell Biol 2006; 7: 14.
20. Satija NK, Gurudutta GU, Sharma S, Afrin F, Gupta P, Verma YK, et al. Mesenchymal stem cells: Molecular targets for tissue engineering. Stem Cells Dev 2007; 16: 7-23.
21. Anjos-Afonso F, Bonnet D. Nonhematopoietic/endothelial SSEA-1+ cells define the most primitive progenitors in the adult murine bone marrow mesenchymal compartment. Blood 2007; 109: 1298-306.
22. Hung SC, Chen H, Pan CY, Tsai MJ, Kao LS, Ma HL. In vitro differentiation of size-sieved stem cells into electrically active neural cells. Stem Cells 2002; 20: 522-9.
23. Kadivar M, Khatami S, Mortazavi Y, Shokrgozar MA, Taghikhani M, Soleimani M. In vitro cardiomyogenic potential of human umbilical vein-derived mesenchymal stem cells. Biochem Biophys Res Commun 2006; 340: 639-47.
24. Kang XQ, Zang WJ, Bao LJ, Li DL, Song TS, Xu XL, et al. Fibroblast growth factor-4 and hepatocyte growth factor induce differentiation of human umbilical cord bloodderived mesenchymal stem cells into hepatocytes. World J Gastroenterol 2005; 11: 7461-5.
25. Pǎunescu V, Deak E, Herman D, Siska IR, Tǎnasie G, Bunu C, et al. In vitro differentiation of human mesenchymal stem cells to epithelial lineage. J Cell Mol Med 2007; 11: 502-8.
26. Le Blanc K, Tammik C, Rosendahl K, Zetterberg E, Ringden O. HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Exp Hematol 2003; 31: 890-6.
27. Nauta AJ, Fibbe WE. Immunomodulatory properties of mesenchymal stromal cells. Blood 2007; 110: 3499-506.
28. François S, Bensidhoum M, Mouiseddine M, Mazurier C, Allenet B, Semont A, et al. Local irradiation not only induces homing of human mesenchymal stem cells at exposed sites but promotes their widespread engraftment to multiple organs: A study of their quantitative distribution after irradiation damage. Stem Cells 2006; 24: 1020-9.
29. Mouiseddine M, François S, Semont A, Sache A, Allenet B, Mathieu N, et al. Human mesenchymal stem cells home specifically to radiation-injured tissues in a non-obese diabetes/severe combined immunodeficiency mouse model. Br J Radiol 2007; 80 (Spec No 1): S49-55.
30. Kinnaird T, Stabile E, Burnett MS, Shou M, Lee CW, Barr S, et al. Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms. Circulation 2004; 109: 1543-9.
31. Chen L, Tredget EE, Wu PY, Wu Y. Paracrine factors of mesenchymal stem cells recruit macrophages and endothelial lineage cells and enhance wound healing. PLoS One 2008; 3: e1886.
32. Koenig KL, Goans RE, Hatchett RJ, Mettler FA Jr, Schumacher TA, Noji EK, et al. Medical treatment of radiological casualties: current concepts. Ann Emerg Med 2005; 45: 643-52.
33. Chambers JA, Purdue GF. Radiation injury and the surgeon. J Am Coll Surg 2007; 204: 128-39.
34. Schull WJ. The somatic effects of exposure to atomic radiation: The Japanese experience, 1947-1997. Proc Natl Acad Sci USA 1998; 95: 5437-41.
35. Fliedner TM, Tibken B, Hofer EP, Paul W. Stem cell responses after radiation exposure: A key to the evaluation and prediction of its effects. Health Phys 1996; 70: 787-97.
36. Yanez R, Lamana ML, Garcia-Castro J, Colmenero I, Ramirez M, Bueren JA. Adipose tissue-derived mesenchymal stem cells have in vivo immunosuppressive properties applicable for the control of graft-versus-host disease. Stem Cells 2006; 24: 2582-91.
37. Le Blanc K, Rasmusson I, Sundberg B, Göthersẗrm C, Hassan M, Uzunel M, et al. Treatment of severe acute graft-versushost disease with third party haploidentical mesenchymal stem cells. Lancet 2004; 363: 1439-41.
38. Ringden O, Uzunel M, Rasmusson I, Remberger M, Sundberg B, Lonnies H, et al. Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease. Transplant 2006; 81: 1390-7.
39. Lazarus HM, Koc ON, Devine SM, Curtin P, Maziarz RT, Holland HK, et al. Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients. Biol Blood Marrow Transplant 2005; 11: 389-98.
40. Lee ST, Jang JH, Cheong JW, Kim JS, Maemg HY, Hahn JS, et al. Treatment of high-risk acute myelogenous leukemia by myeloablative chemotherapy followed by coinfusion of T cell-depleted haematopoietic stem cells and culture-expanded marrow mesenchymal stem cells from a related donor with one fully mismatched human leucocyte antigen haplotype. Br J Haematol 2002; 118: 1128-31.
41. Aggarwal S, Pittenger MF. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 2005; 105: 1815-22.
42. Ringdén O, Uzunel M, Sundberg B, Lonnies L, Nava S, Gustafsson J, et al. Tissue repair using allogeneic mesenchymal stem cells for hemorrhagic cystitis, pneumomediastinum and perforated colon. Leukemia 2007; 21: 2271-76.
43. Fliedner TM, Nothdurft W, Calvo W. The development of radiation late effects to the bone marrow after single and chronic exposure. Int J Radiat Biol Relat Stud Phys Chem Med 1986; 49: 35-46.
44. Galotto M, Berisso G, Delfino L, Podesta M, Ottaggio L, Dallorso S, et al. Stromal damage as consequence of high-dose chemo/radiotherapy in bone marrow transplant recipients. Exp Hematol 1999; 27: 1460-6.
45. Madhusudhan T, Majumdar SS, Mukhopadhyay A. Degeneration of stroma reduces retention of homed cells in bone marrow of lathally irradiated mice. Stem Cells Dev 2004; 13: 173-82.
46. Zhang J, Niu CH, Ye L, Huang H, He X, Tong WG, et al. Identification of the hematopoietic stem cell niche and control of the niche size. Nature 2003; 425: 836-41.
47. Ma J, Shi M, Li J, Chen B, Wang H, Li B, et al. Senescenceunrelated impediment of osteogenesis from Flk1+ bone marrow mesenchymal stem cells induced by total body irradiation and its contribution to long-term bone and hematopoietic injury. Haematologica 2007; 92: 889-96.
48. Noort WA, Kruisselbrink AB, in't Anker PS, Kruger M, van Bezooijen RL, de Paus RA, et al. Mesenchymal stem cells promote engraftment of human umbilical cord blood-derived CD34(+) cells in NOD/SCID mice. Exp Hematol 2002; 30: 870-8.
49. Park SK, Won JH, Kim HJ, Bae SB, Kim CK, Lee KT, et al. Cotransplantation of human mesenchymal stem cells promotes human CD34+ cells engraftment in a dose-dependent fashion in NOD/SCID Mice. J Korean Med Sci 2007; 22: 412-9.
50. Maitra B, Szekely E, Gjini K, Laughlin MJ, Dennis J, Haynesworth SE, et al. Human mesenchymal stem cells support unrelated donor hematopoietic stem cells and suppress T-cell activation. Bone Marrow Transplant 2004; 33: 597-604.
51. Le Blanc K, Ringden O. Immunobiology of human mesenchymal stem cells and future use in hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2005; 11: 321-34.
52. Thierry D, Bertho JM, Chapel A, Gourmelon P. Cell therapy for the treatment of accidental radiation overexposure. Br J Radiol 2005; 27 (Suppl): 175-9.
53. Anno GH, Baum SJ, Withers HR, Young RW. Symptomatology of acute radiation effects in humans after exposure to doses of 0.5-30 Gy. Health Phys 1986; 56: 821-38.
54. Bishop MR. Potential use of hematopoietic stem cells after radiation injury. Stem Cells 1997; 15 (Suppl 2): 305-10.
55. Baranov A, gale RP, Guskova A, Piatkin E, Selidovkin G, Muravyova L, et al. Bone marrow transplantation after the Chernobyl nuclear accident. New Engl J Med 1989; 321: 205-12.
56. Asano S. Multi-organ involvement: lessons from the experience of one victim of the Tokai-mura criticality accident. Br J Radiol 2005; 27 (Suppl): 9-12.
57. Chamberlain G, Fox J, Ashton B, Middleton J. Concise review: Mesenchymal stem cells: Their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells 2007; 25: 2739-49.
58. Chapel A, Bertho JM, Bensidhoum M, Fouillard L, Young RG, Frick J, et al. Mesenchymal stem cells home to injured tissues when co-infused with hematopoietic cells to treat a radiation-induced multi-organ failure syndrome. J Gene Med 2003; 5: 1028-38.
59. Gazdag AR, Lane JM, Glaser D, Forster RA. Alternatives to autogenous bone graft: efficacy and indications. J Am Acad Orthop Surg 1995; 3: 1-8.
60. Li XQ, Stevenson S, Klein L, Davy DT, Shaffer JW, Goldberg VM. Differential patterns of incorporation and remodeling among various types of bone grafts. Acta Anat (Basel) 1991; 140: 236-44.
61. Arinzeh TL, Peter SJ, Archambault MP, van den Bos C, Gordon S, Kraus K, et al. Allogeneic mesenchymal stem cells regenerate bone in a critical-sized canine segmental defect. J Bone Joint Surg Am 2003; 85-A: 1927-35.
62. van der Dolder J, Farber E, Spauwen PH, Jansen JA. Bone tissue reconstruction using titanium fiber mesh combined with rat bone marrow stromal cells. Biomaterials 2003; 24: 1745-50.
63. Quarto R, Mastrogiacomo M, Cancedda R, Kutepov SM, Mukhachev V, Lavroukov A, et al. Repair of large bone defects with the use of autologous bone marrow stromal cells. N Engl J Med 2001; 344: 385-6.
64. Cancedda R, Quarto R, Giannoni P, Mastrogiacomo M, Muraglia A. Cell therapy and bone repair. Eur Cells Materials 2003; 5: 2-3.
65. Chang SC, Chuang HL, Chen YR, Chen JK, Chung HY, Lu YL, et al. Ex vivo gene therapy in autologous bone marrow stromal stem cells for tissue-engineered maxillofacial bone regeneration. Gene Ther 2003; 10: 2013-9.
66. Gugala Z, Olmsted-Davis EA, Gannon FH, Lindsey RW, Davis AR. Osteoinduction by ex vivo adenovirus-mediated BMP2 delivery is independent of cell type. Gene Ther 2003; 10: 1289-96.
67. Zhang XS, Linkhart TA, Chen ST, Peng H, Wergedal JE, Guttierez GG, et al. Local ex vivo gene therapy with bone marrow stromal cells expressing human BMP4 promotes endosteal bone formation in mice. J Gene Med 2004; 6: 4-15.
68. Zhao Z, Zhao M, Xiao G, Franceschi RT. Gene transfer of the Runx2 transcription factor enhances osteogenic activity of bone marrow stromal cells in vitro and in vivo. Mol Ther 2005; 12: 247-53.
69. Tu Q, Valverde P, Li S, Zhang J, Yang P, Chen J. Osterix overexpression in mesenchymal stem cells stimulates healing of critical-sized defects in murine calvarial bone. Tissue Eng 2007; 13: 2431-40.
70. Wojtowicz AM, Templeman KL, Hutmacher DW, Guldberg RE, Garcia AJ. Runx2 overexpression in bone marrow stromal cells accelerates bone formation in critical-sized femoral defects. Tissue Eng Part A 2010; 16: 2795-808.
71. Kumar S, Wan C, Ramaswamy G, Clemens TL, Ponnazhagan S. Mesenchymal stem cells expressing osteogenic and nagiogenic factors synergistically enhance bone formation in a mouse model of segmental bone defect. Mol Ther 2010; 18: 1026-34.
72. Wakitani S, Goto T, Pineda SJ, Young RG, Mansour JM, Caplan AI, et al. Mesenchymal cell-based repair of large, full thickness defects of articular cartilage. J one Joint Surg Am 1994; 76: 579-92.
73. Im GI, Kim DY, Shin JH, Hyun CW, Cho WH. Repair of cartilage defect in the rabbit with cultured mesenchymal stem cells from bone marrow. J Bone Joint Surg 2001; 83: 289-94.
74. Niehoff P, Wiltfang J, Springer IN, Weppner N, Kimmig B, Acil Y. Increased excretion of collagen crosslinks in irradiated patients indicates destruction of collagen. Int J Radiat Biol 2006; 82: 503-9.
75. Dare A, Hachisu R, Yamaguchi A, Yokose S, Yoshiki S, Okano T. Effects of ionizing radiation on proliferation and differentiation of osteoblast-like cells. J Dent Res 1997; 76: 658-64.
76. Gevorgyan AM, La Scala GC, Sukhu B, Leung IT, Ashrafpour H, Yeung I, et al. Radiation-induced craniofacial bone growth inhibition: in vitro cytoprotection in the rabbit orbitozygomatic complex periosteum-derived cell culture. Plast Reconstr Surg 2008; 121: 763-71.
77. Hamilton SA, Pecaut MJ, Gridley DS, Travis ND, Bandstra ER, Willey JS, et al. A murine model for bone loss from therapeutic and space-relevant sources of radiation. J Appl Physiol 2006; 101: 789-93.
78. Priebe MM. Spinal cord injuries as a result of earthquakes: lessons from Iran and Pakistan. J Spinal Cord Med 2007; 30: 367-8.
79. McMohan SS, Albermann S, Rooney GE, Shaw G, Garcia Y, Sweeney E, et al. Engraftment, migration and differentiation of neural stem cells in the rat spinal cord following contusion injury. Cytotherapy 2010; 12: 313-25.
80. Sahni V, Kessler JA. Stem cell therapies for spinal cord injury. Nat Rev Neurol 2010; 6: 363-72.
81. Chopp M, Zhang XH, Li Y, Wang L, Chen J, Lu D, et al. Spinal cord injury in rat: treatment with bone marrow stromal cell transplantation. Neuro Report 2000; 11: 3001-5.
82. Hofstetter CP, Schwarz EJ, Hess D, Widenfalk J, El Manira A, Prockop DJ, et al. Marrow stromal cells form guiding strands in the injured spinal cord and promote recovery. Proc Natl Acad Sci USA 2002; 99: 2199-204.
83. Lu P, Jones LL, Tsuzynski MH. BDNF-expressing marrow stromal cells support extensive axonal growth at sites of spinal cord injury. Exp Neurol 2005; 191: 344-60.
84. Geffner LF, Santacruz P, Izurieta M, Flor L, Maldonado B, Auad AH, et al. Administration of autologous bone marrow stem cells into spinal cord injury patients via multiple routes is safe and improves their quality of life: comprehensive case studies. Cell transplant 2008; 17: 1277-93.
85. Kang KS, Kim SW, Oh YH, Yu JW, Kim KY, Park HK, et al. A 37-year-old spinal cord-injured female patient, transplanted of multipotent stem cells from human UC blood, with improved sensory perception and mobility, both functionally and morphologically: a case study. Cytotherapy 2005; 7: 368-73.
86. Fathke C, Wilson L, Hutter J, Kapoor V, Smith A, Hocking A, et al. Contribution of bone marrow -derived cells to skin: collagen deposition and wound repair. Stem Cells 2004; 22: 812-22.
87. Wu Y, Zhao RCH, Tredget EE. Concise review: Bone marrow-derived stem/progenitor cells in cutaneous repair and regeneration. Stem Cells 2010; 28: 905-15.
88. Li HH, Fu XB, Ouyang YS, Cai C, Wang J, Sun T. Adult bonemarrow- derived mesenchymal stem cells contribute to wound healing of skin appendages. Cell Tissue Res 2006; 14: 325-35.
89. Sasaki M, Abe R, Fujita Y, Ando S, Inokuma D, Shimizu H. Mesenchymal stem cells are recruited into wounded skin and contribute to wound repair by transdifferentiation into multiple skin cell type. J Immunol 2008; 180: 2581-7.
90. Wu Y, Chen L, Scott PG, Tredget EE. Mesenchymal stem cells enhance wound healing through differentiation and angiogenesis. Stem Cells 2007; 25: 2648-59.
91. Shumakov VI, Onishchenko NA, Rasulov MF, Krasheninnikov ME, Zaidenov VA. Mesenchymal bone marrow stem cells more effectively stimulate regeneration of deep burn wounds than embryonic fibroblasts. Bull Exp Biol Med 2003; 136: 192-5.
92. Lataillade JJ, Doucet C, Bey E, Carsin H, Huet C, Clairand I, et al. New approach to radiation burn treatment by dosimetryguided surgery combined with autologous mesenchymal stem cell therapy. Regen Med 2007; 2: 785-94.
93. Bey E, Prat M, Duhamel P, Benderitter M, Brachet M, Trompier F, et al. Emerging therapy for improving wound repair of severe radiation burns using local bone marrow-derived stem cell administrations. Wound Rep Reg 2010; 18: 50-8.
94. Ogwang DM. Penetrating abdominal war injuries among the war victims at Lacor Hospital in Gulu, Northern Uganda. East Central Afr J Surg 2001; 6: 71-4.
95. Sémont A, François S, Mouiseddine M, François A, Sache A, Frick J, et al. Mesenchymal stem cells increase self-renewal of small intestinal epithelium and accelerate structural recovery after radiation injury. Adv Exp Med Biol 2006; 585: 19-30.
96. Wei Y, Nie Y, Lai J, Wan YJY, Li Y. Comparison of the population capacity of hematopoietic and mesenchymal stem cells in experimental colitis rat model. Transplant 2009; 88: 42-8.
97. Nemeth K, Leelahavanichkul A, Yuen PST, Mayer B, Parmelee A, Doi K, et al. Bone marrow stromal cells attenuate sepsis via prostaglandin E2-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat Med 2009; 15: 42-9.
98. Zangana AM. Penetrating liver war injury: A report on 676 cases, after Baghdad invasion and Iraqi Civilian war April 2003. Adv Med Dent Sci 2007; 1: 10-4.
99. Almeida-Porada G, Zanjani ED, Porada CD. Bone marrow stem cells and liver regeneration. Exp Hematol 2010; 38: 574-80.
100. Wang X, Willenbring H, Akkari Y, Torimaru Y, Foster M, Al-Dhalimy M, et al. Cell fusion is the principal source of bonemarrow-derived hepatocytes. Nature 2003; 422: 897-901.
101. Almeida-Porada G, Porada CD, Chamberlain J, Torabi A, Zanjani ED. Formation of human hepatocytes by human hematopoietic stem cells in sheep. Blood 2004; 104: 2582-90.
102. Aurich H, Sgodda M, Kaltwasser P, Vetter M, Weise A, Liehr T, et al. Hepatocyte differentiation of mesenchymal stem cells from human adipose tissue in vitro promotes hepatic integration in vivo. Gut 2009; 58: 570-81.
103. Kuo TK, Hung SP, Chuang CH, Chen CT, Shih YR, Fang SC, et al. Stem cell therapy for liver disease: parameters governing the success of using bone marrow mesenchymal stem cells. Gastroenterology 2008; 134: 2111-21.
104. Banas A, Teratani T, Yamamoto Y, Tokuhara M, Takeshita F, Osaki M, et al. IFATS collection: in vivo therapeutic potential of human adipose tissue mesenchymal stem cells after transplantation into mice with liver injury. Stem Cells 2008; 26: 2705-12.
105. Colletti E, Airey JA, Liu W, Simmons PJ, Zanjani ED, Porada CD, et al. Generation of tissue-specific cells by MSC does not require fusion or donor to host mitochondrial/membrane transfer. Stem Cell Res 2009; 2: 125-38.
106. am Esch JS 2nd, Knoefel WT, Klein M, Ghodsizad A, Fuerst G, Poll LW, et al. Portal application of autologous CD133+ bone marrow cells to the liver: a novel concept to support hepatic regeneration. Stem Cells 2005; 23: 463-70.
107. Levicar N, Pai M, Habib NA, Tait P, Jiao LR, Marley SB, et al. Long-term clinical results of autologous infusion of mobilized adult bone marrow derived CD34+ cells in patients with chronic liver disease. Cell Prolif 2008; 41 (Suppl1): 115-25.
108. Lyra AC, Soares MBP, da Silva LFM, Braga EL, Oliveira SA, Fortes MF, et al. Infusion of autologous bone marrow mononuclear cells through hepatic artery results in a shortterm improvement of liver function in patients with chronic liver disease: a pilot randomized controlled study. Eur J Gastroenterol Hepatol 2010; 22: 33-42.
109. Kharaziha P, Hellstrom PM, Noorinayer B, Farzaneh F, Aghajani K, Jafari F, et al. Improvement of liver function in liver cirrhosis patients after autologous mesenchymal stem cell injection: a phase I-II clinical trial. Eur J Gastroenterol Hepatol 2009; 21: 1199-205.
110. Butkus DE. Post-traumatic acute renal failure in combat casualties: a historical review. Mil Med 1984; 149: 117-24.
111. Bywaters EG, Beall D. Crush injuries with impairment of renal function. Br Med J 1941; 1: 427-32.
112. Kantarci G, Vanholder R, Tuglular S, Akin H, Koç M, and özener Ç, et al. Acute renal failure due to crush syndrome during Marmara earthquake. Am J Kidney Dis 2002; 40: 682-9.
113. Herrera MB, Bussolati B, Bruno S, Fonsato V, Romanazzi GM, Camussi G. Mesenchymal stem cells contribute to the renal repair of acute tubular epithelial injury. Int J Mol Med 2004; 14: 1035-41.
114. Qian H, Yang H, Xu W, Yan Y, Chen Q, Zhu W, et al. Bone marrow mesenchymal stem cells ameliorate rat acute renal failure by differentiating into renal tubular epithelial-like cells. Int J Mol Med 2008; 22: 325-32.
115. Kunter U, Rong S, Djuric Z, Boor P, Müller-Newen G, Yu D, et al. Transplanted mesenchymal stem cells accelerate glomerular healing in experimental glomerulonephritis. J Am Soc Nephrol 2006; 17: 2202-12.
116. Togel F, Hu Z, Weiss K, Isaac J, Lange C, Westenfelder C. Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiationindependent mechanism. Am J Physiol Renal Physiol 2005; 289: F31-F42.
117. Cohen EP. Radiation nephropathy after bone marrow transplantation. Kidney Int 2000; 58: 903-18.
118. Lin F, Cordes K, Li L, Hood L, Couser WG, Shankland SJ et al. Hematopoietic cells contribute to the regeneration of renal tubules after ischemia-reperfusion injury in mice. J Am Soc Nephrol 2005; 14: 1188-99.
119. Fang TC, Alison MR, Cook HT, Jeffery R, Wright NA, Poulsom R. Proliferation of bone marrow-derived cells contributes to regeneration after folic acid-induced acute tubular injury. J Am Soc Nephrol 2005; 16: 1723-32.
120. Imai N, Kaur T, Rosenberg ME, Gupta S. Cellular therapy for kidney diseases. Semin Dial 2009; 22: 629-35.
121. Reinders MEJ, Fibbe WE, Rabelink TJ. Multipotent mesenchymal stromal cell therapy in renal disease and kidney transplantation. Nephrol Dial Transplant 2010; 25: 17-24.